On November 10th, Jin10 Data reported that due to the withdrawal of the issuance application by Jiangxi Shimei Pharmaceutical Co., Ltd. and sponsor Guojin Securities Co., Ltd., the Shenzhen Stock Exchange decided to terminate its ChiNext issuance listing review.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Shenzhen Stock Exchange terminates the review of Simcere Pharmaceutical's ChiNext IPO
On November 10th, Jin10 Data reported that due to the withdrawal of the issuance application by Jiangxi Shimei Pharmaceutical Co., Ltd. and sponsor Guojin Securities Co., Ltd., the Shenzhen Stock Exchange decided to terminate its ChiNext issuance listing review.